Page last updated: 2024-10-24

verapamil and Glycogen Storage Disease Type V

verapamil has been researched along with Glycogen Storage Disease Type V in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.

Research Excerpts

ExcerptRelevanceReference
"Eleven patients, comprising three cases of McArdle's disease and eight with an exertional muscle pain syndrome (EMPS) of unknown cause, entered a double-blind crossover study of verapamil and placebo."9.06A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. ( Lane, RJ; Turnbull, DM; Walton, J; Welch, JL, 1986)
"Eleven patients, comprising three cases of McArdle's disease and eight with an exertional muscle pain syndrome (EMPS) of unknown cause, entered a double-blind crossover study of verapamil and placebo."5.06A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. ( Lane, RJ; Turnbull, DM; Walton, J; Welch, JL, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lane, RJ2
Turnbull, DM2
Hudgson, P1
Walton, J2
Welch, JL1

Trials

2 trials available for verapamil and Glycogen Storage Disease Type V

ArticleYear
Trials of verapamil and dantrolene sodium in McArdle disease.
    Muscle & nerve, 1984, Volume: 7, Issue:7

    Topics: Calcium; Clinical Trials as Topic; Dantrolene; Glycogen Storage Disease; Glycogen Storage Disease Ty

1984
A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain.
    Muscle & nerve, 1986, Volume: 9, Issue:7

    Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Glycogen Storage Disease; Glycogen Sto

1986